Colgate Deflects Currency Crush Through Oral Care Sales, Price Hikes
This article was originally published in The Tan Sheet
Executive Summary
Price increases in some regions are crucial to its earnings while Colgate also looks to oral care product launches as sales drivers. With an oral care business that is “one of the few remaining category killers,” the firm could create more value by divesting its home care and pet product businesses, an analyst says.
You may also be interested in...
North America Anchors Colgate As Currency Headwinds Continue Abroad
Innovation across categories helped make Colgate's North American business its star segment in the second quarter, rising 1.6% to $793m on strong oral care sales, while the firm’s international business remains impacted negatively by currency headwinds.
North America Anchors Colgate As Currency Headwinds Continue Abroad
Innovation across categories helped make Colgate's North American business its star segment in the second quarter, rising 1.6% to $793m on strong oral care sales, while the firm’s international business remains impacted negatively by currency headwinds.
Despite ‘Almost Nonexistent’ Cough/Cold Season, Perrigo's 2020 Consumer Health Sales Grow 6%
Perrigo is latest consumer health firm to note substantially slower flu rates slammed OTC drug sales during 2020 fourth quarter. Its total cough/cold product sales for the year were off $63m on decreases of $34m in the Americas and $29m in its international markets.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: